{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/neutropenic-sepsis/","result":{"data":{"firstChapter":{"id":"ade08997-70b7-5f71-ace1-e47c80bdc07a","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field bfa08f9f-fdde-41c2-bfa1-a7568ad0605f --><h1>Neutropenic sepsis: Summary</h1><!-- end field bfa08f9f-fdde-41c2-bfa1-a7568ad0605f -->","htmlStringContent":"<!-- begin item fcfff318-215b-470a-93bb-e2c8f1061c4f --><!-- begin field 30294244-1315-4848-b9a0-ba13bbc30426 --><ul><li>Neutropenic sepsis is a potentially life-threatening complication of neutropenia (low neutrophil count). It is defined as a temperature of greater than 38°C or any symptoms and/or signs of sepsis, in a person with an absolute neutrophil count of 0.5 x 10<sup>9</sup>/L or lower.<ul><li>Sepsis is a syndrome defined as life-threatening organ dysfunction due to a dysregulated host response to infection.</li><li>Febrile neutropenia is the most common complication of anticancer treatment, and describes the presence of fever in a person with neutropenia.</li></ul></li><li>There are multiple possible causes of neutropenia such as cytotoxic chemotherapy and other immunosuppressive drugs, stem cell transplantation, infections, bone marrow disorders such as aplastic anaemia and myelodysplastic syndromes, and nutritional deficiencies.<ul><li>The risk of infection and/or sepsis increases with severe and/or prolonged neutropenia, and a rapid decline in neutrophil count.</li></ul></li><li>Possible complications of neutropenic sepsis include organ failure, invasive and atypical infection, coagulopathy, encephalopathy and delirium, psychological sequelae and death. </li><li>A diagnosis of neutropenic sepsis should be suspected in any person with known neutropenia or risk factors for neutropenia, and/or risk factors for neutropenic sepsis, who:<ul><li>Has symptoms or signs indicating possible infection (may be minimal, atypical, or absent).</li><li>Becomes unwell.</li><li>Has a temperature greater than 38°C (may be afebrile or have a low temperature).</li><li>Has clinical features of possible sepsis (may be minimal, atypical, or absent).</li><li>Has concern from a relative or carer that there is a change in appearance or behaviour.</li></ul></li><li>Urgent assessment of a person with suspected neutropenic sepsis should include:<ul><li>Evaluation for physiological symptoms and signs to identify the risk of serious complications.</li></ul></li><li>Management of a person with suspected neutropenic sepsis should include implementation of the 'Sepsis Six' bundle of care within the first hour following recognition of sepsis by:<ul><li>Arranging emergency transfer to hospital (usually by 999 ambulance) if the person is critically unwell.</li><li>Arranging emergency transfer to the local oncology or haematology unit, or medical assessment unit, if the person is clinically stable, depending on local referral pathways.</li></ul></li><li>Management of a person with a confirmed diagnosis of neutropenic sepsis following hospital discharge should include:<ul><li>Liaising with the person's specialist if there is any uncertainty or concern regarding the clinical presentation, such as persistent fever.</li><li>Providing advice on the nature of sepsis, what to expect during recovery after sepsis, and sources of information and support.</li><li>Providing information on how and when to seek specialist advice on any symptoms or concerns, and when to seek emergency care, for example if there is fever, signs of infection, or the person is feeling unwell.</li><li>Assessing and managing any complications following sepsis.</li></ul></li></ul><!-- end field 30294244-1315-4848-b9a0-ba13bbc30426 --><!-- end item fcfff318-215b-470a-93bb-e2c8f1061c4f -->","topic":{"id":"c8aa50da-234b-5d4d-b2b3-1ae1d89115e0","topicId":"08d261eb-f269-42a7-801b-2cfddf69a31c","topicName":"Neutropenic sepsis","slug":"neutropenic-sepsis","aliases":[],"chapters":[{"id":"ade08997-70b7-5f71-ace1-e47c80bdc07a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"999bcfa1-3c00-58e5-8186-5b889008a21f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9ff15809-1783-50bc-8cc4-5fb56eb08252","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"1c09fe06-1c69-51ad-8cc6-a0823851753f","slug":"changes","fullItemName":"Changes"},{"id":"1914dca9-ff88-5330-9b92-27f7df59493c","slug":"update","fullItemName":"Update"}]},{"id":"ed21973f-408a-58e8-912b-7bd2b9d0b718","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"58b41c14-2b33-5d1a-b538-099b3fca97fa","slug":"goals","fullItemName":"Goals"},{"id":"c647afae-0cce-504a-b6c3-2af1cf1df43b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9ef3011a-bd82-5da3-ad4c-e33e63dfb333","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1ff2a9b1-3f7b-5c06-8db0-0061ed24ddb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"eea45e78-ce2a-5043-85e2-4acda94fa67e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"167786d0-fb09-53a6-b02d-05105c74f541","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bafe86b3-b06d-52ce-9da2-4373bfa1b619","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"4adba361-ab85-5502-b0b7-ccd33f58b0f9","slug":"definition","fullItemName":"Definition"},{"id":"048bb40e-2b5d-5e2d-8205-4cb6c5986b71","slug":"causes","fullItemName":"Causes"},{"id":"53c0b23f-7fa2-5824-b31e-6277f40216a8","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"751f6798-f767-50f9-b2b5-b23b45bc02cd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1b791a2a-8fd9-5d7c-8986-d1e27bf8e0dc","slug":"complications","fullItemName":"Complications"},{"id":"432b2287-33da-5d24-bf96-4c7e3cf898a9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2422aa1e-8340-5487-8466-e27286e03762","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"338f02ac-53b8-56c4-a0d0-df9873cabe95","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"292306b5-1418-5247-90d7-fe7ddd283226","slug":"assessment","fullItemName":"Assessment"}]},{"id":"a7a279c8-f7ee-50ec-90b2-5441d36ecceb","slug":"management","fullItemName":"Management","subChapters":[{"id":"28f8b375-c46b-5444-98d8-f753fae4bcfa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5a36b1f2-e382-5001-8945-0cef6e53ec83","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c0e91f63-5078-5363-b15a-7db7cc483396","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"740f1b28-1eb9-5160-9dd6-5a1e00f5e8c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17c51bf6-cc58-58c7-8a0a-d6caed83c5b6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c53a0347-9a44-5b20-b1b4-1adfa5b3f959","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"460cc4fe-21c5-57de-9ae3-4c27bc1ab338","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a88ff1aa-1ddd-5785-a592-ebfafff8da3e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8205950b-1254-5a4b-a51a-4a887c9da60d","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"c8aa50da-234b-5d4d-b2b3-1ae1d89115e0","topicId":"08d261eb-f269-42a7-801b-2cfddf69a31c","topicName":"Neutropenic sepsis","slug":"neutropenic-sepsis","aliases":[],"topicSummary":"Neutropenic sepsis is a major cause of death in people with neutropenia. It is a time-critical medical emergency","lastRevised":"Last revised in March 2020","nextPlannedReviewBy":"2024-07-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2024-06","nextPlannedReviewByDisplay":"June 2024","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"46239e57-7990-560a-810f-b31000558649","name":"Cancer","slug":"cancer"},{"id":"ef40c5ff-41df-5fad-804e-7629896151bb","name":"Haematology","slug":"haematology"}],"chapters":[{"id":"ade08997-70b7-5f71-ace1-e47c80bdc07a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"999bcfa1-3c00-58e5-8186-5b889008a21f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9ff15809-1783-50bc-8cc4-5fb56eb08252","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"1c09fe06-1c69-51ad-8cc6-a0823851753f","slug":"changes","fullItemName":"Changes"},{"id":"1914dca9-ff88-5330-9b92-27f7df59493c","slug":"update","fullItemName":"Update"}]},{"id":"ed21973f-408a-58e8-912b-7bd2b9d0b718","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"58b41c14-2b33-5d1a-b538-099b3fca97fa","slug":"goals","fullItemName":"Goals"},{"id":"c647afae-0cce-504a-b6c3-2af1cf1df43b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9ef3011a-bd82-5da3-ad4c-e33e63dfb333","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1ff2a9b1-3f7b-5c06-8db0-0061ed24ddb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"eea45e78-ce2a-5043-85e2-4acda94fa67e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"167786d0-fb09-53a6-b02d-05105c74f541","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bafe86b3-b06d-52ce-9da2-4373bfa1b619","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"4adba361-ab85-5502-b0b7-ccd33f58b0f9","slug":"definition","fullItemName":"Definition"},{"id":"048bb40e-2b5d-5e2d-8205-4cb6c5986b71","slug":"causes","fullItemName":"Causes"},{"id":"53c0b23f-7fa2-5824-b31e-6277f40216a8","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"751f6798-f767-50f9-b2b5-b23b45bc02cd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1b791a2a-8fd9-5d7c-8986-d1e27bf8e0dc","slug":"complications","fullItemName":"Complications"},{"id":"432b2287-33da-5d24-bf96-4c7e3cf898a9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2422aa1e-8340-5487-8466-e27286e03762","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"338f02ac-53b8-56c4-a0d0-df9873cabe95","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"292306b5-1418-5247-90d7-fe7ddd283226","slug":"assessment","fullItemName":"Assessment"}]},{"id":"a7a279c8-f7ee-50ec-90b2-5441d36ecceb","slug":"management","fullItemName":"Management","subChapters":[{"id":"28f8b375-c46b-5444-98d8-f753fae4bcfa","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5a36b1f2-e382-5001-8945-0cef6e53ec83","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"c0e91f63-5078-5363-b15a-7db7cc483396","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"740f1b28-1eb9-5160-9dd6-5a1e00f5e8c1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"17c51bf6-cc58-58c7-8a0a-d6caed83c5b6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c53a0347-9a44-5b20-b1b4-1adfa5b3f959","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"460cc4fe-21c5-57de-9ae3-4c27bc1ab338","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a88ff1aa-1ddd-5785-a592-ebfafff8da3e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8205950b-1254-5a4b-a51a-4a887c9da60d","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"c8aa50da-234b-5d4d-b2b3-1ae1d89115e0"}},"staticQueryHashes":["3666801979"]}